The University of Chicago Header Logo

Connection

Harvey M. Golomb to Middle Aged

This is a "connection" page, showing publications Harvey M. Golomb has written about Middle Aged.
Connection Strength

0.468
  1. A phase II study of 9-aminocamptothecin in advanced non-small-cell lung cancer. Ann Oncol. 1998 Oct; 9(10):1085-90.
    View in: PubMed
    Score: 0.011
  2. Vinorelbine (Navelbine), cisplatin, and concomitant radiation therapy for advanced malignancies of the chest: a Phase I study. Semin Oncol. 1996 Apr; 23(2 Suppl 5):48-52.
    View in: PubMed
    Score: 0.009
  3. Familial myeloid leukemia associated with loss of the long arm of chromosome 5. Leukemia. 1996 Apr; 10(4):669-74.
    View in: PubMed
    Score: 0.009
  4. Randomized comparison of pentostatin versus interferon alfa-2a in previously untreated patients with hairy cell leukemia: an intergroup study. J Clin Oncol. 1995 Apr; 13(4):974-82.
    View in: PubMed
    Score: 0.009
  5. A phase I trial of concomitant chemoradiotherapy with cisplatin dose intensification and granulocyte-colony stimulating factor support for advanced malignancies of the chest. Cancer Chemother Pharmacol. 1995; 35(4):304-12.
    View in: PubMed
    Score: 0.008
  6. Pentostatin treatment for hairy cell leukemia patients who failed initial therapy with recombinant alpha-interferon: a report of CALGB study 8515. Leukemia. 1994 Dec; 8(12):2037-40.
    View in: PubMed
    Score: 0.008
  7. A phase II study of cisplatin, 5-fluorouracil, and leucovorin augmented by vinorelbine (Navelbine) for advanced non-small cell lung cancer: rationale and study design. Semin Oncol. 1994 Oct; 21(5 Suppl 10):79-83; discussion 83-4.
    View in: PubMed
    Score: 0.008
  8. Interferon treatment for hairy cell leukemia. An update on a cohort of 69 patients treated from 1983 to 1986. Leuk Lymphoma. 1994; 14 Suppl 1:89-93.
    View in: PubMed
    Score: 0.008
  9. Hairy cell leukaemia. Baillieres Clin Haematol. 1993 Dec; 6(4):887-98.
    View in: PubMed
    Score: 0.008
  10. Acute myeloid leukaemia following interferon-alfa treatment of hairy cell leukaemia. Br J Haematol. 1993 Mar; 83(3):519-20.
    View in: PubMed
    Score: 0.007
  11. Interferon treatment for hairy cell leukemia: an update on a cohort of 69 patients treated from 1983-1986. Leukemia. 1992 Nov; 6(11):1177-80.
    View in: PubMed
    Score: 0.007
  12. The impact on survival by adjuvant chemotherapy and radiation therapy in stage II non-small-cell lung cancer. Am J Clin Oncol. 1992 Oct; 15(5):405-11.
    View in: PubMed
    Score: 0.007
  13. 5-Fluorouracil with oral leucovorin and hydroxyurea and concomitant radiotherapy for stage III non-small cell lung cancer. Cancer. 1990 Aug 01; 66(3):437-42.
    View in: PubMed
    Score: 0.006
  14. Sex-associated differences in presentation and survival in patients with lung cancer. J Clin Oncol. 1990 Aug; 8(8):1402-7.
    View in: PubMed
    Score: 0.006
  15. B-cell growth factor-induced and alpha-interferon-inhibited proliferation of hairy cells coincides with modulation of cell surface antigens. Cancer Res. 1990 Jul 01; 50(13):4111-20.
    View in: PubMed
    Score: 0.006
  16. Long-term survival of patients with intermediate and high grade lymphoma treated with COMLA/ABP. Leukemia. 1990 Feb; 4(2):127-31.
    View in: PubMed
    Score: 0.006
  17. Efficacy of computed tomography of the thorax and upper abdomen and whole-body gallium scintigraphy for staging of lung cancer. Cancer. 1989 Oct 01; 64(7):1404-8.
    View in: PubMed
    Score: 0.006
  18. Low-dose interferon alfa-2b in the treatment of hairy cell leukemia. J Natl Cancer Inst. 1989 Aug 02; 81(15):1172-4.
    View in: PubMed
    Score: 0.006
  19. Is there a direct differentiation-inducing effect of human recombinant interferon on hairy cell leukemia in vitro? Cancer. 1989 Jul 15; 64(2):374-8.
    View in: PubMed
    Score: 0.006
  20. Neoadjuvant vindesine, etoposide, and cisplatin for locally advanced non-small cell lung cancer. Final report of a phase 2 study. Chest. 1989 Jul; 96(1):110-3.
    View in: PubMed
    Score: 0.006
  21. High-dose, multiple-alkylator chemotherapy with autologous bone marrow reinfusion in patients with advanced non-small cell lung cancer. Cancer. 1989 Jan 15; 63(2):238-42.
    View in: PubMed
    Score: 0.006
  22. Prognostic variables in hairy cell leukemia after splenectomy as initial therapy. Cancer. 1988 Dec 01; 62(11):2420-4.
    View in: PubMed
    Score: 0.006
  23. Skeletal complications in hairy cell leukemia: diagnosis and therapy. J Clin Oncol. 1988 Aug; 6(8):1280-4.
    View in: PubMed
    Score: 0.005
  24. Specific chromosomal abnormalities in acute nonlymphocytic leukemia correlate with drug susceptibility in vivo. Leukemia. 1988 Feb; 2(2):79-83.
    View in: PubMed
    Score: 0.005
  25. Rapid response to 2'-deoxycoformycin in advanced hairy cell leukemia after failure of interferons alpha and gamma. Am J Hematol. 1988 Jan; 27(1):60-2.
    View in: PubMed
    Score: 0.005
  26. Prophylactic cranial irradiation in adenocarcinoma of the lung. A possible role. Cancer. 1987 Jun 15; 59(12):2016-9.
    View in: PubMed
    Score: 0.005
  27. Sequential evaluation of alpha-2b-interferon treatment in 128 patients with hairy cell leukemia. Semin Oncol. 1987 Jun; 14(2 Suppl 2):13-7.
    View in: PubMed
    Score: 0.005
  28. Phase II study of carboplatin in previously untreated patients with metastatic small cell lung carcinoma. Cancer Treat Rep. 1987 Mar; 71(3):311-2.
    View in: PubMed
    Score: 0.005
  29. Hairy cell leukemia and mucormycosis. Treatment with alpha-2 interferon. Am J Med. 1986 Dec; 81(6):1065-7.
    View in: PubMed
    Score: 0.005
  30. Modified stage I (T1N0M0, T2N0M0), nonsmall cell lung cancer: treatment results, recurrence patterns, and adjuvant immunotherapy. Surgery. 1986 Oct; 100(4):621-8.
    View in: PubMed
    Score: 0.005
  31. The role of interferon in the treatment of hairy cell leukemia. Semin Oncol. 1986 Sep; 13(3 Suppl 2):21-8.
    View in: PubMed
    Score: 0.005
  32. Alpha-2 interferon therapy of hairy-cell leukemia: a multicenter study of 64 patients. J Clin Oncol. 1986 Jun; 4(6):900-5.
    View in: PubMed
    Score: 0.005
  33. Responses of hairy cell leukemia cells to a recombinant alpha-2 interferon in vitro and in vivo: correlation between formation of tubuloreticular structures and clinical parameters. J Biol Response Mod. 1986 Jun; 5(3):270-81.
    View in: PubMed
    Score: 0.005
  34. Disseminated atypical mycobacterial infection in patients with hairy cell leukemia. Am J Med. 1986 May; 80(5):891-6.
    View in: PubMed
    Score: 0.005
  35. Local recurrence of resectable non-oat cell carcinoma of the lung. A warning against conservative treatment for N0 and N1 disease. Cancer. 1986 Feb 01; 57(3):471-6.
    View in: PubMed
    Score: 0.005
  36. Second malignancies in hairy cell leukemia. Cancer. 1985 Sep 15; 56(6):1462-7.
    View in: PubMed
    Score: 0.004
  37. Hairy-cell leukemia associated with Hodgkin's disease: a case report. Am J Hematol. 1985 Apr; 18(4):413-9.
    View in: PubMed
    Score: 0.004
  38. Diagnosis and management of synchronous lung cancers. J Thorac Cardiovasc Surg. 1985 Mar; 89(3):378-85.
    View in: PubMed
    Score: 0.004
  39. Autopsy findings in hairy cell leukemia. Semin Oncol. 1984 Dec; 11(4):370-80.
    View in: PubMed
    Score: 0.004
  40. Current concepts in small cell carcinoma of the lung. CA Cancer J Clin. 1984 Sep-Oct; 34(5):269-81.
    View in: PubMed
    Score: 0.004
  41. Hairy cell leukemia. Curr Probl Cancer. 1984 Jan; 8(7):1-39.
    View in: PubMed
    Score: 0.004
  42. Hairy cell leukemia: the importance of accurate diagnosis and sequential management. Adv Intern Med. 1984; 29:245-69.
    View in: PubMed
    Score: 0.004
  43. Hairy cell leukemia: lessons learned in twenty-five years. J Clin Oncol. 1983 Oct; 1(10):652-6.
    View in: PubMed
    Score: 0.004
  44. Lack of efficacy of vinblastine and cisplatin in patients with progressive small cell carcinoma of the lung. Cancer Treat Rep. 1983 Sep; 67(9):831-2.
    View in: PubMed
    Score: 0.004
  45. Non-small cell carcinoma of the lung. Semin Oncol. 1983 Mar; 10(1):1-122.
    View in: PubMed
    Score: 0.004
  46. Guided biopsies of abnormalities on nuclear bone scans. Technique and indications. J Thorac Cardiovasc Surg. 1983 Mar; 85(3):396-403.
    View in: PubMed
    Score: 0.004
  47. Response to splenectomy in 65 patients with hairy cell leukemia: an evaluation of spleen weight and bone marrow involvement. Blood. 1983 Feb; 61(2):349-52.
    View in: PubMed
    Score: 0.004
  48. Absence of prolonged benefit of initial leukapheresis therapy for hairy cell leukemia. Am J Hematol. 1983 Feb; 14(1):49-56.
    View in: PubMed
    Score: 0.004
  49. Correlation of occupation and karyotype in adults with acute nonlymphocytic leukemia. Blood. 1982 Aug; 60(2):404-11.
    View in: PubMed
    Score: 0.004
  50. Phagocytic capacity of hairy cells from seventeen patients. Virchows Arch B Cell Pathol Incl Mol Pathol. 1982; 40(3):327-37.
    View in: PubMed
    Score: 0.003
  51. Phospholipid and cholesterol differences amongst leukemic cell types with special reference to hairy cell leukemia: a preliminary report. Clin Chim Acta. 1981 Nov 11; 116(3):311-8.
    View in: PubMed
    Score: 0.003
  52. Significance of cytogenetic abnormalities in acute leukemias. Hum Pathol. 1981 Jun; 12(6):515-22.
    View in: PubMed
    Score: 0.003
  53. A phase II trial of 9-aminocaptothecin (9-AC) as a 120-h infusion in patients with non-small cell lung cancer. Invest New Drugs. 2001; 19(4):329-33.
    View in: PubMed
    Score: 0.003
  54. Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatin. Blood. 2000 Nov 01; 96(9):2981-6.
    View in: PubMed
    Score: 0.003
  55. Surface immunoglobulin, lectin-induced cap formation, and phagocytic function in five patients with the leukemic phase of hairy cell leukemia. Cancer. 1980 Jul 01; 46(1):50-5.
    View in: PubMed
    Score: 0.003
  56. Susceptibility gene for familial acute myeloid leukemia associated with loss of 5q and/or 7q is not localized on the commonly deleted portion of 5q. Genes Chromosomes Cancer. 2000 Jun; 28(2):164-72.
    View in: PubMed
    Score: 0.003
  57. The benefits of open lung biopsy in patients with previous non-diagnostic transbronchial lung biopsy. A guide to appropriate therapy. Chest. 1980 May; 77(5):647-50.
    View in: PubMed
    Score: 0.003
  58. Hairy cell leukemia: effect of 'hairy' cells on normal granulopoiesis in vitro. Exp Hematol. 1979 Sep; 7(8):411-5.
    View in: PubMed
    Score: 0.003
  59. Evolution of karyotypes in acute nonlymphocytic leukemia. Cancer Res. 1979 Sep; 39(9):3619-27.
    View in: PubMed
    Score: 0.003
  60. Chromosome abnormalities in poorly differentiated lymphocytic lymphoma. Cancer Res. 1979 Aug; 39(8):3119-28.
    View in: PubMed
    Score: 0.003
  61. Splenectomy as initial therapy in twenty-six patients with leukemic reticuloendotheliosis (hairy cell leukemia). Cancer Res. 1979 Jul; 39(7 Pt 1):2366-70.
    View in: PubMed
    Score: 0.003
  62. Small-cell carcinoma of the lung: the prognostic significance of stage on survival. Eur J Cancer (1965). 1979 Jun; 15(6):859-65.
    View in: PubMed
    Score: 0.003
  63. Hairy cell leukemia: differences in phagocytic capacity of cells in vitro. Virchows Arch B Cell Pathol Incl Mol Pathol. 1979 May 04; 30(1):1-13.
    View in: PubMed
    Score: 0.003
  64. Correction of platelet defect after splenectomy in hairy cell leukemia. JAMA. 1979 Apr 20; 241(16):1684.
    View in: PubMed
    Score: 0.003
  65. Hairy cell leukemia: an autopsy study. Cancer. 1979 Apr; 43(4):1339-49.
    View in: PubMed
    Score: 0.003
  66. Banding studies of chromosomal abnormalities in patients with acute lymphocytic leukemia. Cancer Res. 1979 Jan; 39(1):227-38.
    View in: PubMed
    Score: 0.003
  67. Metastatic non-oat-cell bronchogenic carcinoma. Therapy with cyclophosphamide, doxorubicin, methotrexate, and procarbazine (CAMP). JAMA. 1978 Dec 15; 240(25):2743-6.
    View in: PubMed
    Score: 0.003
  68. Hairy cell leukemia: an analysis of the chromosomes of 26 patients. Virchows Arch B Cell Pathol. 1978 Nov 17; 29(1-2):113-20.
    View in: PubMed
    Score: 0.003
  69. Disseminated atypical mycobacterial infection in hairy-cell leukaemia. Lancet. 1978 Nov 11; 2(8098):1052-3.
    View in: PubMed
    Score: 0.003
  70. Hairy cell leukemia: a clinical review based on 71 cases. Ann Intern Med. 1978 Nov; 89(5 Pt 1):677-83.
    View in: PubMed
    Score: 0.003
  71. Correlation of clinical findings with quinacrine-banded chromosomes in 90 adults with acute nonlymphocytic leukemia: an eight-year study (1970-1977). N Engl J Med. 1978 Sep 21; 299(12):613-9.
    View in: PubMed
    Score: 0.003
  72. Hairy cell leukemia: diagnosis and management. CA Cancer J Clin. 1978 Sep-Oct; 28(5):265-77.
    View in: PubMed
    Score: 0.003
  73. Hairy cell leukemia: an unusual lymphoproliferative disease: a study of 24 patients. Cancer. 1978 Aug; 42(2 Suppl):946-56.
    View in: PubMed
    Score: 0.003
  74. Phase I study of vinorelbine, cisplatin, and concomitant thoracic radiation in the treatment of advanced chest malignancies. J Clin Oncol. 1998 Jun; 16(6):2157-63.
    View in: PubMed
    Score: 0.003
  75. A phase I-II study of paclitaxel, ifosfamide, and vinorelbine with filgrastim (rhG-CSF) support in advanced non-small-cell lung cancer. Ann Oncol. 1998 Jun; 9(6):677-80.
    View in: PubMed
    Score: 0.003
  76. Hexamethylmelamine, bleomycin, and CCNU chemotherapy for patients with squamous cell carcinoma, large cell carcinoma, and adenocarcinoma of the lung unresponsive to cyclophosphamide, adriamycin, methotrexate, and procarbazine. Cancer Treat Rep. 1978 Apr; 62(4):567-9.
    View in: PubMed
    Score: 0.003
  77. Chromosome abnormalities in patients with hairy cell leukemia. Cancer. 1978 Apr; 41(4):1374-80.
    View in: PubMed
    Score: 0.003
  78. Hairy cell leukaemia: evidence for the existence of a spectrum of functional characteristics. Br J Haematol. 1978 Feb; 38(2):161-70.
    View in: PubMed
    Score: 0.003
  79. Phase I study of docetaxel with concomitant thoracic radiation therapy. J Clin Oncol. 1998 Jan; 16(1):159-64.
    View in: PubMed
    Score: 0.003
  80. Phase I study of vinorelbine and ifosfamide in advanced non-small-cell lung cancer. J Clin Oncol. 1997 Mar; 15(3):884-92.
    View in: PubMed
    Score: 0.002
  81. Hairy-cell leukaemia. Lancet. 1977 Feb 12; 1(8007):372-3.
    View in: PubMed
    Score: 0.002
  82. An approach to general oncology: principles and procedures. J Reprod Med. 1976 Oct; 17(4):191-7.
    View in: PubMed
    Score: 0.002
  83. Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP)--effective four-drug combination chemotherapy for metastatic non-oat cell bronchogenic carcinoma. Cancer Treat Rep. 1976 Sep; 60(9):1225-30.
    View in: PubMed
    Score: 0.002
  84. Malignant pleural effusion as complication of chronic lymphocytic leukaemia. Lancet. 1976 Aug 21; 2(7982):414-5.
    View in: PubMed
    Score: 0.002
  85. Acute nonlymphocytic leukemia in adults: correlations with Q-banded chromosomes. Blood. 1976 Jul; 48(1):9-21.
    View in: PubMed
    Score: 0.002
  86. Ifosfamide-based combination chemotherapy in advanced non-small cell lung cancer: two phase I studies. Semin Oncol. 1996 Jun; 23(3 Suppl 6):11-5.
    View in: PubMed
    Score: 0.002
  87. Ifosfamide-based chemotherapy for non-small cell lung cancer: phase I/II studies at the University of Chicago. Semin Oncol. 1996 Jun; 23(3 Suppl 7):15-8.
    View in: PubMed
    Score: 0.002
  88. Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer. Semin Oncol. 1996 Apr; 23(2 Suppl 5):11-8.
    View in: PubMed
    Score: 0.002
  89. A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer. Cancer J Sci Am. 1995 Nov-Dec; 1(4):288-94.
    View in: PubMed
    Score: 0.002
  90. Paclitaxel and ifosfamide: a multicenter phase I study in advanced non-small cell lung cancer. Semin Oncol. 1995 Aug; 22(4 Suppl 9):38-41.
    View in: PubMed
    Score: 0.002
  91. Estrogen receptor. Therapeutic guide in undifferentiated metastatic carcinoma in women. Arch Intern Med. 1975 Jul; 135(7):942-5.
    View in: PubMed
    Score: 0.002
  92. Recombinant alpha-2b-interferon in therapy of previously untreated hairy cell leukemia: long-term follow-up results of study by Cancer and Leukemia Group B. Leukemia. 1995 Jul; 9(7):1116-20.
    View in: PubMed
    Score: 0.002
  93. Dose intensification--a phase I study of ifosfamide with vinorelbine (Navelbine): rationale and study design in advanced non-small cell lung cancer. Semin Oncol. 1995 Apr; 22(2 Suppl 5):30-7; discussion 41-4.
    View in: PubMed
    Score: 0.002
  94. The Sézary syndrome cell: surface ultrastructural characteristics. Acta Haematol. 1975; 54(2):106-14.
    View in: PubMed
    Score: 0.002
  95. Increased incidence of second neoplasms in patients treated with interferon alpha 2b for hairy cell leukemia: a clinicopathologic assessment. Blood. 1994 May 15; 83(10):2931-8.
    View in: PubMed
    Score: 0.002
  96. Expression of the IFN alpha receptor in hairy cell leukaemia. Br J Haematol. 1992 Nov; 82(3):541-6.
    View in: PubMed
    Score: 0.002
  97. A phase I study of cisplatin, 5-fluorouracil and leucovorin with escalating doses of hydroxyurea in chemotherapy naive patients. Eur J Cancer. 1991; 27(2):217-8.
    View in: PubMed
    Score: 0.002
  98. Is pelvic irradiation necessary in stage III1A Hodgkin's disease? Int J Radiat Oncol Biol Phys. 1990 Sep; 19(3):715-9.
    View in: PubMed
    Score: 0.002
  99. Peripheral blood-derived stem cell collections for use in autologous transplantation after high dose chemotherapy: an alternative approach. Bone Marrow Transplant. 1990 Feb; 5(2):129-33.
    View in: PubMed
    Score: 0.002
  100. The patterns of failure in patients with pathological stage I and II diffuse histiocytic lymphoma treated with radiation therapy alone. Int J Radiat Oncol Biol Phys. 1989 Oct; 17(4):767-71.
    View in: PubMed
    Score: 0.001
  101. Radiation therapy for pathologic stage III Hodgkin's disease with and without chemotherapy. Int J Radiat Oncol Biol Phys. 1989 Oct; 17(4):761-6.
    View in: PubMed
    Score: 0.001
  102. The clinical significance of karyotype in acute myelogenous leukemia. Cancer Genet Cytogenet. 1989 Jul 15; 40(2):203-16.
    View in: PubMed
    Score: 0.001
  103. Cost-benefit analysis of interferon alfa-2b in treatment of hairy cell leukemia. J Natl Cancer Inst. 1989 Apr 19; 81(8):594-602.
    View in: PubMed
    Score: 0.001
  104. Relapse after interferon alfa-2b therapy for hairy-cell leukemia: analysis of prognostic variables. J Clin Oncol. 1988 Nov; 6(11):1714-21.
    View in: PubMed
    Score: 0.001
  105. Extended mantle radiation therapy for pathologic stage I and II Hodgkin's disease. J Clin Oncol. 1988 Jun; 6(6):1047-52.
    View in: PubMed
    Score: 0.001
  106. Adenosquamous lung carcinoma: clinical characteristics, treatment, and prognosis. Ann Thorac Surg. 1987 Nov; 44(5):462-6.
    View in: PubMed
    Score: 0.001
  107. Use and prognostic value of staging mediastinoscopy in non-small-cell lung cancer. Surgery. 1987 Oct; 102(4):652-9.
    View in: PubMed
    Score: 0.001
  108. Pleural involvement in stage IIIM0 non-small-cell bronchogenic carcinoma. A need to differentiate subtypes. Am J Clin Oncol. 1986 Jun; 9(3):255-61.
    View in: PubMed
    Score: 0.001
  109. Regional accuracy of computed tomography of the mediastinum in staging of lung cancer. J Thorac Cardiovasc Surg. 1986 Apr; 91(4):498-504.
    View in: PubMed
    Score: 0.001
  110. The role of adjuvant therapy after resection of T1 N1 M0 and T2 N1 M0 non-small cell lung cancer. J Thorac Cardiovasc Surg. 1986 Mar; 91(3):344-9.
    View in: PubMed
    Score: 0.001
  111. Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7. J Clin Oncol. 1986 Mar; 4(3):325-45.
    View in: PubMed
    Score: 0.001
  112. Changes in peripheral blood and bone marrow specimens following therapy with recombinant alpha 2 interferon for hairy cell leukemia. Am J Clin Pathol. 1986 Feb; 85(2):194-201.
    View in: PubMed
    Score: 0.001
  113. Protochemotherapy in non-small cell lung carcinoma. An attempt to increase surgical resectability and survival. A preliminary report. Cancer. 1986 Jan 01; 57(1):44-53.
    View in: PubMed
    Score: 0.001
  114. Treatment of diffuse histiocytic lymphoma (DHL) with COMLA (cyclophosphamide, oncovin, methotrexate, leucovorin, cytosine arabinoside): a 10-year experience in a single institution. J Clin Oncol. 1985 Dec; 3(12):1596-604.
    View in: PubMed
    Score: 0.001
  115. CAMP chemotherapy for metastatic non-oat cell bronchogenic carcinoma. A 7-year experience (1975-1981) with 160 patients. Cancer. 1985 Nov 15; 56(10):2385-90.
    View in: PubMed
    Score: 0.001
  116. Long-term survival of patients with localized diffuse histiocytic lymphoma. J Clin Oncol. 1985 Oct; 3(10):1309-17.
    View in: PubMed
    Score: 0.001
  117. Malignant superior vena cava obstruction reconsidered: the role of diagnostic surgical intervention. Ann Thorac Surg. 1985 Sep; 40(3):285-8.
    View in: PubMed
    Score: 0.001
  118. Pathologic stages IA and IIA Hodgkin's disease: results of treatment with radiotherapy alone (1968-1980). J Clin Oncol. 1985 Jun; 3(6):758-68.
    View in: PubMed
    Score: 0.001
  119. Treatment of hairy cell leukemia with recombinant alpha 2 interferon. Blood. 1985 Mar; 65(3):644-8.
    View in: PubMed
    Score: 0.001
  120. Combined modality therapy for Stage IIIMO non-small cell lung cancer. A five-year experience. Cancer. 1984 Jul 01; 54(1):5-12.
    View in: PubMed
    Score: 0.001
  121. A morphologic and cytochemical study of acute myelomonocytic leukemia with abnormal marrow eosinophils associated with inv(16)(p13q22). Am J Clin Pathol. 1984 Jun; 81(6):733-41.
    View in: PubMed
    Score: 0.001
  122. Evidence for a 15;17 translocation in every patient with acute promyelocytic leukemia. Am J Med. 1984 May; 76(5):827-41.
    View in: PubMed
    Score: 0.001
  123. Trial of vindesine, etoposide, and cisplatin in patients with previously treated, advanced-stage, non-small cell bronchogenic carcinoma. Cancer Treat Rep. 1984 Feb; 68(2):413-5.
    View in: PubMed
    Score: 0.001
  124. Initial alkylating agent chemotherapy in a leukemic hairy cell patient. Am J Hematol. 1984 Jan; 16(1):91-4.
    View in: PubMed
    Score: 0.001
  125. The predictive value of initial cytogenetic studies in 148 adults with acute nonlymphocytic leukemia: a 12-year study (1970-1982). Cancer Genet Cytogenet. 1983 Nov; 10(3):219-36.
    View in: PubMed
    Score: 0.001
  126. Association of an inversion of chromosome 16 with abnormal marrow eosinophils in acute myelomonocytic leukemia. A unique cytogenetic-clinicopathological association. N Engl J Med. 1983 Sep 15; 309(11):630-6.
    View in: PubMed
    Score: 0.001
  127. Treatment of modified Stage II (T1 N1 M0, T2 N1 M0) non-small cell bronchogenic carcinoma. A combined modality approach. J Thorac Cardiovasc Surg. 1983 Aug; 86(2):180-5.
    View in: PubMed
    Score: 0.001
  128. Morphologic and cytochemical observations on the overt leukemic phase of therapy-related leukemia. Am J Clin Pathol. 1983 May; 79(5):525-30.
    View in: PubMed
    Score: 0.001
  129. Development of dysmyelopoietic syndrome in a hairy cell leukemia patient treated with chlorambucil: cytogenetic and morphologic evaluation. Cancer Genet Cytogenet. 1983 Feb; 8(2):107-15.
    View in: PubMed
    Score: 0.001
  130. Metastatic non-small cell bronchogenic carcinoma: a randomized trial of sequential vs combination chemotherapy. Eur J Cancer Clin Oncol. 1983 Jan; 19(1):33-8.
    View in: PubMed
    Score: 0.001
  131. Increased cholesterol biosynthesis in leukemic cells from patients with hairy cell leukemia. Blood. 1983 Jan; 61(1):50-60.
    View in: PubMed
    Score: 0.001
  132. Unique cell surface glycoprotein expression in hairy cell leukemia: effect of phorbol ester tumor promoters on surface glycoproteins, cell morphology, and adherence. Cancer Res. 1982 Sep; 42(9):3724-8.
    View in: PubMed
    Score: 0.001
  133. Response to 5-azacytidine in patients with refractory acute nonlymphocytic leukemia and association with chromosome findings. Cancer. 1982 Jun 01; 49(11):2222-5.
    View in: PubMed
    Score: 0.001
  134. Prognostic factors in patients with non-small cell bronchogenic carcinoma and brain metastases. Cancer. 1982 May 01; 49(9):1916-9.
    View in: PubMed
    Score: 0.001
  135. Bronchogenic carcinoma located in the aortic window. The importance of the primary lesion as a determinant of survival. J Thorac Cardiovasc Surg. 1982 Apr; 83(4):551-62.
    View in: PubMed
    Score: 0.001
  136. Prognostic significance of posttransfusion hepatitis and chromosomal abnormalities in adult acute nonlymphocytic leukemia. Cancer Genet Cytogenet. 1982 Apr; 5(4):281-92.
    View in: PubMed
    Score: 0.001
  137. Hairy cell leukemia in father and son. Cancer. 1981 Oct 15; 48(8):1825-9.
    View in: PubMed
    Score: 0.001
  138. Nonrandom chromosome abnormalities in acute leukemia and dysmyelopoietic syndromes in patients with previously treated malignant disease. Blood. 1981 Oct; 58(4):759-67.
    View in: PubMed
    Score: 0.001
  139. Hairy cell leukemia: association with disseminated atypical mycobacterial infection. Cancer. 1981 Jul 15; 48(2):380-3.
    View in: PubMed
    Score: 0.001
  140. Lymphoblastic lymphoma in adults. Cancer. 1981 May 15; 47(10):2510-6.
    View in: PubMed
    Score: 0.001
  141. Diffuse histiocytic lymphoma with sclerosis: a clinicopathologic entity frequently causing superior venacaval obstruction. Cancer. 1981 Feb 15; 47(4):748-56.
    View in: PubMed
    Score: 0.001
  142. Late relapses in Hodgkin disease. Am J Hematol. 1981; 10(1):31-6.
    View in: PubMed
    Score: 0.001
  143. Small-cell carcinoma of the lung: a five-year experience with combined modality therapy. Cancer. 1980 Dec 15; 46(12):2550-6.
    View in: PubMed
    Score: 0.001
  144. Cyclophosphamide, vincristine, methotrexate with leucovorin rescue, and cytarabine (COMLA) combination sequential chemotherapy for advanced diffuse histiocytic lymphoma. Ann Intern Med. 1980 Jun; 92(6):785-90.
    View in: PubMed
    Score: 0.001
  145. Dysmyelopoietic syndrome: sequential clinical and cytogenetic studies. Blood. 1980 Apr; 55(4):636-44.
    View in: PubMed
    Score: 0.001
  146. Chromosomes and causation of human cancer and leukemia. XXXV. The missing Y in acute non-lymphocytic leukemia (ANLL). Cancer. 1980 Jan 01; 45(1):84-90.
    View in: PubMed
    Score: 0.001
  147. Sequential staging in bronchogenic carcinoma. Chest. 1979 Dec; 76(6):653-7.
    View in: PubMed
    Score: 0.001
  148. Chromosome analysis of primary large bowel tumors: a new method for improving the yield of analyzable metaphases. Cancer. 1979 Nov; 44(5):1656-64.
    View in: PubMed
    Score: 0.001
  149. Pathologic stage I and II Hodgkin's disease, 1968--1975: relapse and results of retreatment. Cancer. 1979 Jul; 44(1):72-9.
    View in: PubMed
    Score: 0.001
  150. Evolution of karyotypes in Philadelphia (Ph1) chromosome-negative chronic myelogenous leukemia. Cancer. 1979 Feb; 43(2):411-6.
    View in: PubMed
    Score: 0.001
  151. Scintigraphic evaluation of sarcomata in children and adults by Ga67 citrate. Cancer. 1978 Oct; 42(4):1760-5.
    View in: PubMed
    Score: 0.001
  152. Acute nonlymphocytic leukemia in malignant lymphoma: a morphologic study. Cancer. 1978 Jul; 42(1):229-42.
    View in: PubMed
    Score: 0.001
  153. Non-Hodgkin's lymphoma, poorly differentiated lymphocytic and mixed cell types: results of sequential staging procedures, response to therapy, and survival of 100 patients. Cancer. 1978 Jul; 42(1):88-95.
    View in: PubMed
    Score: 0.001
  154. The leukemic phase of histiocytic lymphoma. Histologic, cytologic, cytochemical, ultrastructural, immunologic and cytogenetic observations in a case. Am J Clin Pathol. 1978 May; 69(5):550-8.
    View in: PubMed
    Score: 0.001
  155. Sepsis in treated Hodgkin's disease. Am J Med. 1978 May; 64(5):914-5.
    View in: PubMed
    Score: 0.001
  156. Chromosomal aneuploidy in a patient with hypereosinophilic syndrome. Evidence for a malignant disease. Am J Med. 1977 Dec; 63(6):1010-4.
    View in: PubMed
    Score: 0.001
  157. The clinical features of chronic lymphocytic leukaemia. Clin Haematol. 1977 Feb; 6(1):185-202.
    View in: PubMed
    Score: 0.001
  158. Survival of patients with localized histiocytic lymphoma. Cancer. 1977 Jan; 39(1):342-6.
    View in: PubMed
    Score: 0.001
  159. Idiopathic acquired refractory sideroblastic anemia: Banded chromosome analysis in six patients. Acta Haematol. 1977; 57(1):15-23.
    View in: PubMed
    Score: 0.001
  160. Acute monocytic leukemia. Cytologic, histologic, cytochemical, ultrastructural, and cytogenetic observations. Am J Clin Pathol. 1976 Apr; 65(4):471-82.
    View in: PubMed
    Score: 0.001
  161. Bone marrow involvement in non-Hodgkin's lymphoma: implications for staging and therapy. Cancer. 1976 Feb; 37(2):629-36.
    View in: PubMed
    Score: 0.001
  162. Combination chemotherapy of lymphomas other than Hodgkin's disease. Ann Intern Med. 1974 Nov; 81(5):601-8.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.